JP2013186124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013186124A5 JP2013186124A5 JP2013043157A JP2013043157A JP2013186124A5 JP 2013186124 A5 JP2013186124 A5 JP 2013186124A5 JP 2013043157 A JP2013043157 A JP 2013043157A JP 2013043157 A JP2013043157 A JP 2013043157A JP 2013186124 A5 JP2013186124 A5 JP 2013186124A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- gpibα
- vwf
- solid phase
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12158022.9A EP2637024A1 (de) | 2012-03-05 | 2012-03-05 | Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion |
| EP12158022.9 | 2012-03-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013186124A JP2013186124A (ja) | 2013-09-19 |
| JP2013186124A5 true JP2013186124A5 (enExample) | 2016-03-03 |
| JP6199050B2 JP6199050B2 (ja) | 2017-09-20 |
Family
ID=47722189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013043157A Active JP6199050B2 (ja) | 2012-03-05 | 2013-03-05 | ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9766234B2 (enExample) |
| EP (2) | EP2637024A1 (enExample) |
| JP (1) | JP6199050B2 (enExample) |
| ES (1) | ES2575778T3 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007031708A1 (de) * | 2007-07-06 | 2009-01-08 | Dade Behring Marburg Gmbh | Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin |
| EP2637024A1 (de) | 2012-03-05 | 2013-09-11 | Siemens Healthcare Diagnostics Products GmbH | Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion |
| EP2919013B1 (de) | 2014-03-11 | 2016-11-02 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur Detektion von Modulatoren der GPIb-Thrombin-Interaktion |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69940058D1 (de) * | 1998-04-23 | 2009-01-22 | Ajinomoto Kk | Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin |
| ES2358576T3 (es) | 1999-07-05 | 2011-05-11 | K.U. LEUVEN RESEARCH & DEVELOPMENT | Detección de la actividad del factor de von-willebrand (vwf). |
| DE102006019520A1 (de) * | 2006-04-27 | 2007-11-08 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung hoher Ristocetin-Kofaktor-Aktivitäten des von-Willebrand-Faktors |
| DE102007031708A1 (de) | 2007-07-06 | 2009-01-08 | Dade Behring Marburg Gmbh | Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin |
| EP2193373A4 (en) | 2007-08-23 | 2010-07-28 | Bloodct Of Wisconsin Inc | METHODS AND KITS FOR MEASURING VON WILLEBRAND FACTOR |
| EP2637024A1 (de) | 2012-03-05 | 2013-09-11 | Siemens Healthcare Diagnostics Products GmbH | Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion |
-
2012
- 2012-03-05 EP EP12158022.9A patent/EP2637024A1/de not_active Withdrawn
-
2013
- 2013-02-25 ES ES13156498.1T patent/ES2575778T3/es active Active
- 2013-02-25 EP EP13156498.1A patent/EP2637025B1/de active Active
- 2013-02-28 US US13/779,904 patent/US9766234B2/en active Active
- 2013-03-05 JP JP2013043157A patent/JP6199050B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Forsström et al. | Dissecting antibodies with regards to linear and conformational epitopes | |
| JP2011500091A5 (enExample) | ||
| WO2015038884A3 (en) | Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products | |
| WO2014204939A3 (en) | Methods for quantitative determination of protein-nucleic acid interactions in complex mixtures | |
| MX2017011489A (es) | Detección de moléculas pequeñas mediante nanoporos a través de ensayos de competición. | |
| ZA202002415B (en) | Detection of symmetrical dimethylarginine | |
| JP2016516735A5 (enExample) | ||
| EA201490745A1 (ru) | Полипептиды антител, которые вызывают антагонизм cd40l | |
| CN102892885B (zh) | IgA结合性肽以及利用其的IgA的纯化 | |
| JP2012517017A5 (enExample) | ||
| RU2015120601A (ru) | Эритроферрон и erfe-полипептиды и способы регуляции метаболизма железа | |
| Li et al. | Identification of IgE and IgG epitopes on native Bos d 4 allergen specific to allergic children | |
| JP2016528236A5 (enExample) | ||
| JP2012073273A5 (enExample) | ||
| JP2016520846A5 (enExample) | ||
| MX2014010068A (es) | Metodos y sistemas para amplificacion de señal de bioensayos. | |
| JP2017510627A5 (enExample) | ||
| MX353464B (es) | Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles. | |
| JP2013186124A5 (enExample) | ||
| JP2015529211A5 (enExample) | ||
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| JP2020521460A5 (enExample) | ||
| Vagida et al. | Flow analysis of individual blood extracellular vesicles in acute coronary syndrome | |
| JP6515923B2 (ja) | クレアチンキナーゼｍｂアイソザイムの測定方法及びそれに用いられるキット | |
| JPWO2014157723A1 (ja) | インスリン測定方法 |